Table 2. Design matrix for optimization of papain purity and total activity using CCD.
Run | CPEG (%, w/w) | Csalt (%, w/w) | pH | Papain purity* (%) | Total activity of PEG phase (nkat) |
1 | 0 (16) | −2 (10) | 0 (6) | 92.05±1.8 | 18.57±0.2 |
2 | 1 (18) | 1 (16) | 1 (7) | 97.45±1.9 | 2.94±0.1 |
3 | −1 (14) | 1 (16) | −1 (5) | 92.33±0.9 | 20.67±0.2 |
4 | 1 (18) | −1 (12) | 1 (7) | 97.42±1.0 | 12.30±0.2 |
5 | 1 (18) | −1 (12) | −1 (5) | 89.42±0.9 | 22.74±0.7 |
6 | −1 (14) | 1 (16) | 1 (7) | 97.86±2.0 | 8.24±0.2 |
7 | 0 (16) | 0 (14) | 0 (6) | 98.11±1.0 | 18.41±0.2 |
8 | 0 (16) | 2 (18) | 0 (6) | 100.00±1.0 | 3.32±0.1 |
9 | 0 (16) | 0 (14) | 2 (8) | 96.75±1.9 | 1.27±0.1 |
10 | −1 (14) | −1 (12) | −1 (5) | 87.59±1.8 | 23.10±0.5 |
11 | 0 (16) | 0 (14) | −2 (4) | 82.85±0.8 | 24.62±0.7 |
12 | 0 (16) | 0 (14) | 0 (6) | 96.01±1.0 | 17.24±0.2 |
13 | 0 (16) | 0 (14) | 0 (6) | 98.64±1.0 | 16.46±0.3 |
14 | −2 (12) | 0 (14) | 0 (6) | 96.35±1.9 | 18.95±0.2 |
15 | 2 (20) | 0 (14) | 0 (6) | 97.95±0.5 | 12.13±0.1 |
16 | 0 (16) | 0 (14) | 0 (6) | 98.14±1.0 | 18.16±0.7 |
17 | −1 (14) | −1 (12) | 1 (7) | 96.16±0.5 | 13.36±0.1 |
18 | 1 (18) | 1 (16) | −1 (5) | 96.22±1.0 | 17.77±0.2 |
19 | 0 (16) | 0 (14) | 0 (6) | 96.45±1.9 | 17.53±0.2 |
20 | 0 (16) | 0 (14) | 0 (6) | 97.53±1.0 | 17.72±0.1 |
Actual variables are given in parentheses.
*Determined by FPLC.